PKD1L2 and polycystic ovary syndrome: PKD1L2 expression was detected to be among the most downregulated in the adipose tissue of polycystic ovary syndrome (PCOS) patients [32], suggesting that Pkd1l2 could function as a potential biomarker for PCOS diagnosis.